Results and outlook; Key growth products; Pipeline and portfolio development; Partnerships, collaborations and acquisitions; Re-focusing R&D and the pipeline; Phase III pipeline; Phase II and early stage; Biologics
Results and outlook; Key growth products; Pipeline and portfolio development; Partnerships, collaborations and acquisitions; Re-focusing R&D and the pipeline; Phase III pipeline; Phase II and early stage; Biologics